Q32 Bio (QTTB) Shares Outstanding (2017 - 2026)
Q32 Bio's (QTTB) quarterly Shares Outstanding (Entity) came in at $14.6 million in Q1 2026, up 19.94% year-on-year from $12.2 million in Q1 2025, and up 13.78% quarter-over-quarter from $12.9 million in Q4 2025.
Q32 Bio (QTTB) Shares Outstanding (2017 - 2026) Analysis & Trends
Q32 Bio's Shares Outstanding (Entity) history runs 9 years deep, the most recent figure standing at $14.6 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Entity) rose 19.94% year-over-year to $14.6 million in Q1 2026; TTM through Mar 2026 was $14.6 million, a 19.94% increase from a year earlier, with the FY2025 full-year figure at $12.9 million, up 37.95% from the prior year.
- Shares Outstanding (Entity) grew to $14.6 million in Q1 2026 per QTTB's latest filing, from $12.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $14.6 million in Q1 2026 and bottomed at $995280.0 in Q1 2024.
- The 5-year median for Shares Outstanding (Entity) is $3.2 million (2023), against an average of $7.3 million.
- Across the five-year window, Shares Outstanding (Entity) sank 69.0% in 2024 and surged 1125.55% in 2025, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $3.2 million in 2022, then increased by 0.93% to $3.2 million in 2023, then soared by 189.16% to $9.3 million in 2024, then jumped by 37.95% to $12.9 million in 2025, then gained by 13.78% to $14.6 million in 2026.
- Per Business Quant, the three latest QTTB Shares Outstanding (Entity) figures stand at $14.6 million (Q1 2026), $12.9 million (Q4 2025), and $12.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | 14.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.10 Mn |
| Dec 31, 2025 | 12.30 Mn |
| Sep 30, 2025 | 12.24 Mn |
| Jun 30, 2025 | 12.20 Mn |
| Mar 31, 2025 | 12.20 Mn |
| Dec 31, 2024 | 9.32 Mn |
| Sep 30, 2024 | 12.08 Mn |
| Jun 30, 2024 | 11.96 Mn |
| Mar 31, 2024 | 995,280.00 |
| Dec 31, 2023 | 3.21 Mn |
| Sep 30, 2023 | 3.21 Mn |
| Jun 30, 2023 | 3.21 Mn |
| Mar 31, 2023 | 3.21 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Sep 30, 2022 | 3.19 Mn |
| Jun 30, 2022 | 3.19 Mn |
| Mar 31, 2022 | 3.18 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | 3.17 Mn |
| Jun 30, 2021 | 3.14 Mn |